Ranolazine Improves Glycemic Variability and Endothelial Function in Patients with Diabetes and Chronic Coronary Syndromes: Results from an Experimental Study.

Annunziata NuscaFederico BernardiniFabio MangiacapraErnesto MaddaloniRosetta MelfiElisabetta RicottiniFrancesco PiccirilloSilvia ManfriniGian Paolo UssiaFrancesco Grigioni

Published in: Journal of diabetes research (2021)

Ranolazine added to standard anti-ischemic and glucose-lowering therapy demonstrated benefit in improving the glycemic status of patients with T2D and CCS. How this improvement contributes to the overall myocardial benefit of ranolazine requires further studies.

Keyphrases

type diabetes
coronary artery disease
coronary artery
glycemic control
left ventricular
blood glucose
heart failure
case control
oxidative stress
aortic stenosis
mesenchymal stem cells
adipose tissue
cell therapy
atrial fibrillation
transcatheter aortic valve replacement
blood brain barrier